choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • TroVax

TroVax Newsletter
  • Oxford BioMedica’s TroVax phase I/II trial yields encouraging results 27 Feb 2017 10:52 GMT

    … 47;II clinical trial of MVA-5T4 immunotherapy (TroVax) and low … I/II clinical trial involving 53 patients with … anti-5T4 responses over the trial period. The study findings … Oxford BioMedica’s immunotherapy (TroVax) treatment could give to patients with …

  • Oxford Biomedica lauds “encouraging” trial results from a Phase I/II cancer... 24 Feb 2017 09:17 GMT

    … product, TroVax for patients with advanced colorectal cancer. The biotech firm said … cancer patients. Commenting on the trial results, John Dawson, Oxford Biomedica … Oxford BioMedica's immunotherapy (TroVax®) treatment could give to patients with …

  • Says Beneficial Anti-Tumour Responses Seen In Trial 24 Feb 2017 09:36 GMT

    … I/II clinical trial of TroVax and low dose cyclophosphamide … I/II clinical trial involved 53 patients with … both its cyclophosphamide and TroVax products independently induced highly … BioMedica noted that the trial was the first randomised study …

  • Therapeutic Vaccines Market to Reach $4.82 billion with 33.6% CAGR Forecast to 2020 10 Nov 2016 03:24 GMT

    … components to the standard cancer treatments.In the pipeline, therapeutic … Other Disease Vaccines), Cancer Vaccines (TroVax, PR1 Peptide Vaccine, Multikine, … Nordic Celtic Pharma Curevac Cytos Biotechnology GlaxoSmithKline Pfizer Merck Kgaa ( …

  • Cancer Vaccines 29 Apr 2016 13:25 GMT

    … and immunotherapies, drug formulations, personalised treatment, immune check … MSD • Christina Derleth, Medical Director, Genentech • Mustafa … Research, Biontech RNA Pharmaceuticals GmbH • Andrew Gengos … : Clinical development of TroVax (MVA-5T4) and …

Satisfied with the content?

Continue to create your account.